Key result
Unsupervised machine learning identifies 6 distinct acute heart failure phenotypes with differing one-year mortality.
Why the study?
Acute heart failure is a heterogeneous disease with varying clinical severity and treatment needs, requiring analysis of its natural phenotypic heterogeneity.
Does unsupervised machine learning clustering identify distinct phenotypes with differing mortality in patients with acute heart failure?
Observational (n=381)
Blinded to outcome
Does unsupervised machine learning clustering identify distinct phenotypes with differing mortality in patients with acute heart failure?
p-value: p=0.002
Unsupervised machine learning can identify distinct clinical phenotypes of acute heart failure that have significantly different one-year mortality rates, potentially aiding in customized treatment and future trial design.
Hypothesis-generating for phenotype-specific AHF management; prospective validation required before clinical adoption.
Acute heart failure (AHF) is a life-threatening, heterogeneous disease requiring urgent diagnosis and treatment. The clinical severity and medical procedures differ according to a complex interplay between the deterioration cause, underlying cardiac substrate, and comorbidities. This study aimed to analyze the natural phenotypic heterogeneity of the AHF population and evaluate the possibilities offered by clustering (unsupervised machine-learning technique) in a medical data assessment. We evaluated data from 381 AHF patients. Sixty-three clinical and biochemical features were assessed at the admission of the patients and were included in the analysis after the preprocessing. The K-medoids algorithm was implemented to create the clusters, and optimization, based on the Davies-Bouldin index, was used. The clustering was performed while blinded to the outcome. The outcome associations were evaluated using the Kaplan-Meier curves and Cox proportional-hazards regressions. The algorithm distinguished six clusters that differed significantly in 58 variables concerning i.e., etiology, clinical status, comorbidities, laboratory parameters and lifestyle factors. The clusters differed in terms of the one-year mortality (p = 0.002). Using the clustering techniques, we extracted six phenotypes from AHF patients with distinct clinical characteristics and outcomes. Our results can be valuable for future trial constructions and customized treatment.
No takes yet. Share an insight, caveat, or question.
Urban et al. (2022) conducted an observational in Acute heart failure (n=381). Unsupervised machine learning-based clustering was evaluated on One-year mortality (p=0.002). Unsupervised machine learning identified six distinct acute heart failure phenotypes that differed significantly in clinical characteristics and one-year mortality (p = 0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: